Masso Torrence Wealth Management’s Renalytix plc American Depositary Shares RNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-76
Closed -$1K 385
2021
Q4
$1K Buy
+76
New +$1.52K ﹤0.01% 389

Other funds holding RNLX

Masso Torrence Wealth Management's RNLX Position: Q1 2022 in Review

Masso Torrence Wealth Management sold out of Renalytix plc American Depositary Shares (RNLX) in Q1 2022, closing a stake of 76 shares — an estimated $1K sold.

Masso Torrence Wealth Management first reported a position in RNLX in Q4 2021 and held it in 1 quarter. The position peaked at $1K in Q4 2021. 35 funds tracked by Wall St. Rank hold RNLX as of Q1 2022.

  • Masso Torrence Wealth Management reported no remaining Renalytix plc American Depositary Shares position as of Q1 2022 after selling out during the quarter.
  • Masso Torrence Wealth Management sold 76 Renalytix plc American Depositary Shares shares in Q1 2022, an estimated $1K.
  • Masso Torrence Wealth Management first reported a position in Renalytix plc American Depositary Shares in Q4 2021 and held it in 1 quarter.
  • Masso Torrence Wealth Management's Renalytix plc American Depositary Shares position peaked at $1K in Q4 2021.
  • 35 funds tracked by Wall St. Rank held Renalytix plc American Depositary Shares as of Q1 2022.

Based on Masso Torrence Wealth Management's 13F filing for Q1 2022, filed 26 Apr 2022.